The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vel'sher L.Z.

kafedra onkologii i luchevoĭ terapii lechebnogo fakul'teta Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Stakhanov M.L.

kafedra onkologii i luchevoĭ terapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Kalinin M.R.

Cancer Center, N.A. Semashko Central Clinical Hospital, OAO «RZhD», Moscow, Russia

Gorchak Yu.Yu.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Anikanova E.V.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Ishevsky G.B.

Cancer Center, N.A. Semashko Central Clinical Hospital, OAO «RZhD», Moscow, Russia

Firsov K.A.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

New focal therapy options in the treatment of patients with prostate cancer

Authors:

Vel'sher L.Z., Stakhanov M.L., Kalinin M.R., Gorchak Yu.Yu., Anikanova E.V., Ishevsky G.B., Firsov K.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(1): 66‑71

DOI: 10.17116/onkolog20154666-71

Read: 1980 times

Download PDF (RU)
Contact the author
Table of contents

NEW FOCAL THERAPY OPTIONS IN THE TREATMENT OF PATIENTS WITH PROSTATE CANCER
NEW FOCAL THERAPY OPTIONS IN THE TREATMENT OF PATIENTS WITH PROSTATE CANCER

To cite this article:

Vel'sher LZ, Stakhanov ML, Kalinin MR, Gorchak YuYu, Anikanova EV, Ishevsky GB, Firsov KA. New focal therapy options in the treatment of patients with prostate cancer. P.A. Herzen Journal of Oncology. 2016;5(1):66‑71. (In Russ.)
https://doi.org/10.17116/onkolog20154666-71

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pote­ntial of specialized diet therapy in redu­cing toxic mani­festations in patients with meta­static castration-resistant prostate cancer with bone meta­stases during radionuclide therapy with radium chlo­ride [223Ra]. P.A. Herzen Journal of Onco­logy. 2024;(6):33-41
Remote resu­lts of treatment of patients with prostate cancer who unde­rwent radiation therapy in a combined version. P.A. Herzen Journal of Onco­logy. 2025;(3):14-19
Global coagulation tests in pharmacological prophylaxis of venous thro­mboembolism in patients with prostate cancer after radi­cal prostatectomy. P.A. Herzen Journal of Onco­logy. 2025;(5):41-46
Patterns of CAF expression in tumors of the geni­tourinary system. Russian Journal of Archive of Pathology. 2024;(6):28-35
Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medi­cine. 2025;(7):111-118
Cost-effectiveness analysis of triptorelin therapy for patients with prostate cancer in state healthcare system of the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):83-92
Abstract:

Prostate cancer ranks second in male cancer morbidity patterns. Different therapeutic approaches from radical treatment to active follow-up are used to treat patients with prostate cancer. A new prostate cancer treatment named focal therapy has recently come into active development. The paper describes focal therapy options, such as laser interstitial thermotherapy, photodynamic therapy, their mechanisms of action and a treatment process and presents the results of foreign trials of the efficiency of these methods. It gives information on the use of an electrochemical lysis method and irreversible electroporation to treat patients with prostate cancer.

Keywords:

prostate cancer
focal therapy
electrochemical lysis

Authors:

Vel'sher L.Z.

kafedra onkologii i luchevoĭ terapii lechebnogo fakul'teta Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Stakhanov M.L.

kafedra onkologii i luchevoĭ terapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Kalinin M.R.

Cancer Center, N.A. Semashko Central Clinical Hospital, OAO «RZhD», Moscow, Russia

Gorchak Yu.Yu.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Anikanova E.V.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Ishevsky G.B.

Cancer Center, N.A. Semashko Central Clinical Hospital, OAO «RZhD», Moscow, Russia

Firsov K.A.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Close metadata

References:

  1. Dostupno po: http://globocan.iarc.fr/Pages/online.aspx. Ssylka aktivna na 17.05.2015.
  2. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2012 godu. Pod red. Kaprina A.D., Starinskogo V.V., Petrovoi G.V. M.: FGBU «MNIOI im. P.A. Gertsena» Minzdrava Rossii; 2013.
  3. Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436-445. doi:10.1056/nejmoa1209978.
  4. Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370:932-942. doi:10.1056/nejmoa1311593.
  5. Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011;29:3669-3676. doi:10.1200/jco.2011.34.9738.
  6. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M. Will focal therapy become a standard of care for men with localised prostate cancer? Nat Clin Pract Oncol. 2007;4(11):632-642. doi:10.1038/ncponc0959.
  7. Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S. Focal therapy for prostate cancer: possibilities and limitations. Eur Urol. 2010;58(1):57-64. doi:10.1016/j.eururo.2010.07.001.
  8. Ahmed HU, Moore C, Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol. 2009;18(3):219-232. doi:10.1016/j.suronc.2009.02.002.
  9. Lindner U, Lawrentschuk N, Davidson SR, Raz O, Hlasny E, Trachtenberg J et al. Focal laser ablation for localized prostate cancer. J Endourol. 2010;24(5):791-797. doi:10.1089/end.2009.0440.
  10. Amin Z, Lees WR, Bown SG. Technical note: interstitial laser photocoagulation for the treatment of prostatic cancer. Br J Radiol. 1993;66(791):1044-1047. doi:10.1259/0007-1285-66-791-1044.
  11. Bown SG. Phototherapy in tumors. World J Surg. 1983;7(6):700-709. doi:10.1007/bf01655209.
  12. Johnson DE, Cromeens DM, Price RE. Pathologic changes following transurethral canine prostatectomy with a cylindrically diffusing fiber. Lasers Surg Med. 1994;14(4):306-313. doi:10.1002/lsm.1900140403.
  13. Lindner U, Weersink RA, Haider MA, Gertner MR, Davidson SR, Atri M et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol. 2009;182:1371-1377. doi:10.1016/j.juro.2009.06.035.
  14. Oto A, Sethi I, Karczmar G, McNichols R, Ivancevic MK, Stadler WM et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013;267:932-940. doi:10.1148/radiol.13121652.
  15. Lee T, Mendhiratta N, Sperling D, Lepor H. Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.Rev Urol. 2014;16(2):55-66. doi:10.3909/riu0615.
  16. Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res. 2003;23:3591-600. doi:10.1039/9781847551658-00001.
  17. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889-905. doi:10.1093/jnci/90.12.889.
  18. Stranadko E.F. Istoricheskii ocherk razvitiya fotodinamicheskoi terapii. Lazernaya meditsina. 2002;6(1):4-8.
  19. Azzouzi AR, Barret E, Moore CM, Villers A, Allen C, Scherz A et al.TOOKAD((R)) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localized prostate cancer. Br J Urol Int. 2013;112(6):766-774. doi:10.1111/bju.12265.
  20. Windal T, Anderson SO, Lofgren L. Photodynamic therapy of localized prostatic cancer. Lancet. 1990;336(8723):1139. doi:10.1016/0140-6736(90)92626-s.
  21. Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, Emberton M et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med. 2006;38(5):356-363. doi:10.1002/lsm.20275.
  22. Moore CM, Azzouzi AR, Barret E, Villers A, Muir G, Barber NJ et al. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localized prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy. Br J UrolInt. 2014;May19. Available at: http://onlinelibrary.wiley.com. Accessed May17, 2015. doi:10.1111/bju.12816.
  23. Emberton MA. European randomized phase 3 study to assess the efficacy and safety of TOOKAD soluble for localized prostate cancer compared to active surveillance. Available at: http://clinicaltrials.gov/ct2/show/NCT01310894. Accessed May 17, 2015.
  24. Vel'sher L.Z., Stakhanov M.L., Gorchak Yu.Yu., Reshetov D.N., Astrakhantsev A.F., Zhashkov R.V. i dr. Funktsional'nye i onkologicheskie rezul'taty bioelektroterapii bol'nykh rakom predstatel'noi zhelezy. V kn.: Kalinin M.R., Lutsevich  O.E., red. Noveishie tekhnologii v klinicheskuyu praktiku. Sbornik nauchnykh rabot. M.; 2009:55-58.
  25. Matveev N.L., Kaplan M.A., Borsukov A.A. Metodika i tekhnika primeneniya elektrokhimicheskogo lizisa v lechenii novoobrazovanii. Rekomendatsii dlya interventsionnykh radiologov, gepatobiliarnykh khirurgov, onkologov. M.; 2005.
  26. Nordenström BEW. Biokinetic impacts on structure and imaging of the lung: the concept of biologically closed electric circuits. Am J Roentgenol. 1985;145(3):447-467. doi:10.2214/ajr.145.3.447.
  27. Xin YL. Advances in the treatment of malignant tumors by electrochemical therapy (ECT). Eur J Surg. 1994;Suppl. 574:31-35. PMID: 7531017.
  28. Xin YL, Liu D. Electrostatic therapy (EST) of lung cancer and pulmonary metastasis: report of 15 cases. Eur J Surg. 1994;Suppl. 574:91-92. PMID: 7531032.
  29. Wang HL. Electrochemical therapy of 74 cases of liver cancer. Eur J Surg. 1994;Suppl. 574:55-57. PMID: 7531022.
  30. Borsukov A.V., Bel'kov A.V., Vlasov A.V., Alibegov R.A., Solov'ev V.I., Andreeva O.V. i dr. Elektrokhimicheskii lizis edinichnykh metastazov v pecheni: rezul'taty dvukhletnego klinicheskogo nablyudeniya 43 bol'nykh. Annaly khirurgicheskoi gepatologii. 2005;10(2):21-29.
  31. Borsukov A.V., Kovalenko E.S., Evdokimov A.N., Momdzhyan B.K. Elektrokhimicheskii lizis kak metod lokal'noi destruktsii pervichnogo raka pecheni pod kontrolem ul'trazvukovogo issledovaniya (v eksperimente). Medi­tsinskaya vizualizatsiya. 2007;2:64-69.
  32. Shchaeva S.N., Solov'ev V.I., Borsukov A.V. Elektrokhimicheskii lizis ochagovykh dobrokachestvennykh opukholei molochnoi zhelezy: vozmozhnosti maloinvazivnogo lokal'nogo lecheniya. Palliativnaya meditsina i reabi­litatsiya. 2006;4:12-18.
  33. Ivanov Yu.V., Popov D.V., Solov'ev N.A., Zlobin A.I. Pervye rezul'taty primeneniya v eksperimente meto­diki elektrokhimicheskogo lizisa v khirurgicheskoi endo­krinologii. Vestnik Natsional'nogo mediko-khirur­gicheskogo tsentra im. N.I. Pirogova. 2010;5(2):18-23.
  34. Borsukov A.V., Ivanov Yu.V., Kosova A.A., Andreeva  O.V., Amirov A.Kh., Solov'ev N.A. Pervye rezul'taty eksperimental'nogo elektrokhimicheskogo lizisa v khirurgicheskoi endokrinologii. Meditsinskii vestnik MVD. 2009;3:6-11.
  35. Belyi Yu.A., Solov'ev D.K. Intraokulyarnyi elektrokhimicheskii lizis kak etap endorezektsii bol'shikh vnutriglaznykh obrazovanii. Vestnik Orenburgskogo gosudarstvennogo universiteta. 2012;12:15-18.
  36. Belyi Yu.A., Tereshchenko A.V., Shatskikh A.V., Solov'ev D.K. Endorezektsiya vnutriglaznogo obrazovaniya s intraokulyarnym elektrokhimicheskim lizisom. Rossiiskii bioterapevticheskii zhurnal. 2013;12(2):9-9a.
  37. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223-231. doi:10.1007/s10439-005-8981-8.
  38. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat. 2007;6(1):37-48. doi:10.1177/153303460700600106.
  39. Onik G, Mikus P, Rubinsky B. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat. 2007;6(4):295-300. doi:10.1177/153303460700600405.
  40. Onik G, Rubinsky B. Irreversible Electroporation: first patient experience focal therapy of prostate cancer. In: Rubinsky B. ed. Irreversible electroporation. Berlin, Heidelberg: Springer-Verlag; 2010:235-247. doi:10.1007/978-3-642-05420-4_10.
  41. Brausi MA, Giliberto GL, Simonini GL, Botticell L, Gresgorio CD. Irreversible electroporation (IRE), a novel technique for focal ablation of prostate cancer (PCa): results of a interim pilot safety study in low risk patients with prostate cancer. Urology. 2011;78(3, Suppl.):S304-S305. doi:10.1016/j.urology.2011.07.949.
  42. Valerio M, Dickinson CL, Ahmed HU, Smith A, Allen C, Emberton M. Irreversible electroporation in the focal treatment of prostate cancer: initial results. In: 6th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer. 29-31 May 2013, Netherlands, Amsterdam. J Eur Urol. 2013;12(1, Suppl.):S584. doi:10.1016/s1569-9056(13)61067-2.
  43. Valerio M, Dickinson L, Ali A, Ramachandran N, Donaldson  I, Freeman A, Ahmed HU, Emberton M. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT). Contemp Clin Trials. 2014;39(1):57-65. Available at: http://clinicaltrials.gov/ct2/show/NCT0172 6894. Accessed May 17, 2015. doi:10.1016/j.cct.2014.07.006.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.